Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline

Publish date: July 27, 2018

 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Is fibromyalgia one disorder – or two?
MDedge Internal Medicine
New studies expand on Aimovig for migraine
MDedge Internal Medicine
How to prescribe effectively for opioid use disorder
MDedge Internal Medicine
Is fish oil’s heart benefit a fish tale?
MDedge Internal Medicine
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Internal Medicine
Weather changes trigger migraine
MDedge Internal Medicine
Guideline: PFO closure best bet for recurrent stroke prevention
MDedge Internal Medicine
Monoclonal antibody slowed cognitive decline, cleared Alzheimer’s plaques in phase 2 trial
MDedge Internal Medicine
Blood pressure meds cut cognitive impairment risk
MDedge Internal Medicine
Alzheimer’s trial design problem throws a wrench in promising BAN2401 results
MDedge Internal Medicine